Pat Kung

Entrepreneur Fellow

Che-Pei (Pat) Kung obtained his PhD degree from the University of North Carolina at Chapel Hill, studying tumorigenic mechanisms mediated by Epstein-Barr virus. After graduation, Pat first worked at the Wistar Institute in Philadelphia, where he identified genetic variations in the tumor suppressor protein p53 that regulate the development of both cancers and diabetes. He is now a TL1 postdoctoral research scholar at Washington University School of Medicine, conducting translational research to develop novel therapeutic approaches in hard-to-treat breast cancers. He is also an entrepreneur fellow at the Skandalaris Center, assisting with applications for SBIR/STTR small business grant mechanisms from the Washington University community.